Drawing for ICHROMA

USPTO serial 86472614

ICHROMA

Reviewed by CopyMark Law Group

Reg. 4976000Status 701Renewal
Filing date
Status date
Registration date
Jun 14, 2016
Examiner
BODRI, JOHN PETER
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with ICHROMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $2,550

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jun-Hwa Jeong

Jun-Hwa Jeong RABIN & BERDO, P.C.8150 Leesburg Pike, Suite 800Vienna, VA 22182United States

Goods and services

ClassDescriptionStatusFirst use
001Biochemical precursors for scientific purposes; Biochemical preparations for scientific purposes; biochemical for in vitro and in vivo scientific use; Biological preparations, other than for medical or veterinary purposes; Biological tissue cultures other than for medical or veterinary purposes; Biological tissue specimens for use in scientific research; Buffer solutions for scientific purposes; Buffer solutions for use in analytical chemistry; Chemically treated non-medical test strips for calibration of laboratory apparatus; Chemically treated non-medical test strips for assays in biotechnology research; Chemical preparations for scientific purposes; Chemical preparations for scientific purposes, other than for medical or veterinary use; Chemical preparations for use in industry; Chemical reagents for scientific purposes; Chemical reagents, other than for medical or veterinary purposes; Chemicals for use in biotechnological product development; Chemicals for use in chromatography; Chemicals for use in science; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Diagnostic preparations for scientific or research use; Diagnostic preparations, other than for medical or veterinary purposes; Diagnostic reagents for scientific or research use; Diagnostic reagents, other than for medical or veterinary purposes; Enzyme preparations for industrial purposes; Enzymes derived from biotechnological processes for use in biotechnology industry; Enzymes for scientific and research purposes; Reagent paper, other than for medical or veterinary purposes; Reagents for chemical analyses; Reagents for medical research; Reagents for research purposes; Reagents for scientific purposes; Reagents for use in scientific apparatus for chemical or biological analysis; Chemical test paperACTIVE—
005Biological and chemical reagents for medical or veterinary purposes; Biological reagents for medical purposes or veterinary purposes; Chemical reagents for medical or veterinary purposes; Clinical diagnostic reagents for medical purposes; Swabs for medical purposes or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic reagents for medical or veterinary purposes; Diagnostic substances for medical or veterinary purposes; Diagnostic test reagents for medical or veterinary purposes; Enzyme preparations for medical or veterinary purposes; Enzymes for medical or veterinary purposes; Reagent paper for medical or veterinary purposes; Medical diagnostic test strips for measuring or detecting biochemical markers in bodily fluids; Medical diagnostic reagents and assays for testing of bodily fluidsACTIVE—
010Medical apparatus for clinical diagnosis of cardiac disease, tumor, diabetes, infectious disease, rheumatoid arthritis, hormone anomalies, sepsis or anemia; Medical apparatus for use in fluorescent analysis to determine the concentration of target analytes in bodily fluids; Medical apparatus for use in immunofluorescence analysis to determine the concentration of target analytes in bodily fluids; Medical apparatus for use in absorbance analysis; Medical apparatus for use in immuno assays to determine the concentration of target analytes in bodily fluids; Medical apparatus for testing bodily fluid samples; Blood testing apparatus; Microcuvettes for medical purposes; Cartridge for test strip, namely, a container for test strips specially adapted for determining the concentration of target analytes in bodily fluids; Capillary tubes for blood; Capillary tubes for delivering reagents; Capillary tubes for samples; Diagnostic apparatus for medical purposes, namely, medical diagnostic apparatus for detecting cardiac disease, tumor, hormone levels, diabetes, infectious disease, rheumatoid arthritis, sepsis or anemia; Incubators for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 10, 2026PR89POST REGISTRATION ACTION MAILED - SEC. 8 & 9—
Aug 10, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 12, 2026E89RTEAS SECTION 8 & 9 RECEIVED—
Jun 14, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jun 6, 2023NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jun 6, 20238.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Jun 6, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 8, 2022ES8RTEAS SECTION 8 RECEIVED—
Jun 14, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 14, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 29, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 29, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 9, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 19, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 11, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 9, 2016DMCCDATA MODIFICATION COMPLETED—
Feb 8, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Feb 8, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 8, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 8, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 28, 2016DMCCDATA MODIFICATION COMPLETED—
Jan 5, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 5, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 5, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 17, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 7, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 17, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 17, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 17, 2015ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 2, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 2, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Oct 2, 2015CNSLSUSPENSION LETTER WRITTEN—
Oct 2, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Oct 2, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 2, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 2, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 3, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 3, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 31, 2015ALIEASSIGNED TO LIE—
Aug 14, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 23, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2015DOCKASSIGNED TO EXAMINER—
Dec 11, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 9, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance